Homology Medicines Stock Total Asset
| FIXXDelisted Stock | USD 1.09 0.06 5.83% |
Homology Medicines fundamentals help investors to digest information that contributes to Homology Medicines' financial success or failures. It also enables traders to predict the movement of Homology Stock. The fundamental analysis module provides a way to measure Homology Medicines' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Homology Medicines stock.
Homology |
Homology Medicines Company Total Asset Analysis
Homology Medicines' Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Homology Medicines Total Asset | 306.12 M |
Most of Homology Medicines' fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Homology Medicines is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, Homology Medicines has a Total Asset of 306.12 M. This is 95.93% lower than that of the Biotechnology sector and 84.51% lower than that of the Health Care industry. The total asset for all United States stocks is 98.96% higher than that of the company.
Homology Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Homology Medicines' direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Homology Medicines could also be used in its relative valuation, which is a method of valuing Homology Medicines by comparing valuation metrics of similar companies.Homology Medicines is currently under evaluation in total asset category among its peers.
Homology Fundamentals
| Return On Equity | -0.9 | |||
| Return On Asset | -0.36 | |||
| Operating Margin | (78.85) % | |||
| Current Valuation | (27 M) | |||
| Shares Outstanding | 3.23 M | |||
| Shares Owned By Insiders | 9.20 % | |||
| Shares Owned By Institutions | 46.75 % | |||
| Number Of Shares Shorted | 338.72 K | |||
| Price To Earning | (10.00) X | |||
| Price To Book | 0.04 X | |||
| Price To Sales | 2.61 X | |||
| Revenue | 1.16 M | |||
| Gross Profit | (95.14 M) | |||
| EBITDA | (91.52 M) | |||
| Net Income | (112.96 M) | |||
| Cash And Equivalents | 201.07 M | |||
| Cash Per Share | 3.50 X | |||
| Total Debt | 1.32 M | |||
| Debt To Equity | 0.14 % | |||
| Current Ratio | 8.44 X | |||
| Book Value Per Share | 22.65 X | |||
| Cash Flow From Operations | (96.23 M) | |||
| Short Ratio | 0.62 X | |||
| Earnings Per Share | (35.10) X | |||
| Price To Earnings To Growth | 21.38 X | |||
| Target Price | 1.5 | |||
| Beta | -0.11 | |||
| Market Capitalization | 3.02 M | |||
| Total Asset | 306.12 M | |||
| Retained Earnings | (542.1 M) | |||
| Working Capital | 72.34 M | |||
| Current Asset | 48.82 M | |||
| Current Liabilities | 8.27 M | |||
| Net Asset | 306.12 M |
About Homology Medicines Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Homology Medicines's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Homology Medicines using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Homology Medicines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Homology Stock
If you are still planning to invest in Homology Medicines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Homology Medicines' history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |